A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis

PurposeIn amyotrophic lateral sclerosis, functional alterations within the brain have been intensively assessed, while progression of lower motor neuron damage has scarcely been defined. The aim of the present study was to develop a computational method to systematically evaluate spinal cord metabolism as a tool to monitor disease mechanisms.MethodsA new computational three-dimensional method to extract the spinal cord from 18F-FDG PET/CT images was evaluated in 30 patients with spinal onset amyotrophic lateral sclerosis and 30 controls. The algorithm identified the skeleton on the CT images by using an extension of the Hough transform and then extracted the spinal canal and the spinal cord. In these regions, 18F-FDG standardized uptake values were measured to estimate the metabolic activity of the spinal canal and cord. Measurements were performed in the cervical and dorsal spine and normalized to the corresponding value in the liver.ResultsUptake of 18F-FDG in the spinal cord was significantly higher in patients than in controls (p < 0.05). By contrast, no significant differences were observed in spinal cord and spinal canal volumes between the two groups. 18F-FDG uptake was completely independent of age, gender, degree of functional impairment, disease duration and riluzole treatment. Kaplan-Meier analysis showed a higher mortality rate in patients with standardized uptake values above the fifth decile at the 3-year follow-up evaluation (log-rank test, p < 0.01). The independence of this value was confirmed by multivariate Cox analysis.ConclusionOur computational three-dimensional method enabled the evaluation of spinal cord metabolism and volume and might represent a potential new window onto the pathophysiology of amyotrophic lateral sclerosis.

[1]  Annalisa Perasso,et al.  Spinal Canal and Spinal Marrow Segmentation by Means of the Hough Transform of Special Classes of Curves , 2015, ICIAP.

[2]  Bruce R. Rosen,et al.  Increased in vivo glial activation in patients with amyotrophic lateral sclerosis: Assessed with [11C]-PBR28 , 2015, NeuroImage: Clinical.

[3]  D. Troost,et al.  Immunohistochemical characterization of the inflammatory infiltrate in amyotrophic lateral sclerosis , 1990, Neuropathology and applied neurobiology.

[4]  John F. Canny,et al.  A Computational Approach to Edge Detection , 1986, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[5]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[6]  David E. Elder.  Thin melanoma. , 2011, Archives of pathology & laboratory medicine.

[7]  Michael Schuetz,et al.  Diagnosis and Prognosis of Traumatic Spinal Cord Injury , 2011, Global spine journal.

[8]  P. Kushner,et al.  Major histocompatibility complex antigen expression in the affected tissues in amyotrophic lateral sclerosis , 1990, Annals of neurology.

[9]  P. Mcgeer,et al.  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. , 1992, The American journal of pathology.

[10]  P. Sham,et al.  Prognostic modelling of therapeutic interventions in amyotrophic lateral sclerosis , 2002, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[11]  Jonathan M. Bekisz,et al.  Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  D. Brooks,et al.  Cortical involvement in four cases of primary lateral sclerosis using [11C]-flumazenil PET , 2007, Journal of Neurology.

[13]  J. Thie.  Understanding the standardized uptake value, its methods, and implications for usage. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  M. Swash,et al.  El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis , 2000, Amyotrophic lateral sclerosis and other motor neuron disorders : official publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases.

[15]  A. Al-Chalabi,et al.  Prolonged survival in motor neuron disease: a descriptive study of the King’s database 1990–2002 , 2003, Journal of neurology, neurosurgery, and psychiatry.

[16]  Adriano Chiò,et al.  Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis , 2014, Neurology.

[17]  A. Chiò,et al.  The metabolic signature of C9ORF72-related ALS: FDG PET comparison with nonmutated patients , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Annalisa Perasso,et al.  Profile Detection in Medical and Astronomical Images by Means of the Hough Transform of Special Classes of Curves , 2014, Journal of Mathematical Imaging and Vision.

[19]  C. Zuo,et al.  MRI and FDG PET/CT findings in 3 cases of spinal infectious arachnoiditis. , 2014, Clinical nuclear medicine.

[20]  A. Chiò,et al.  Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[21]  P. Mccombe,et al.  The Role of Immune and Inflammatory Mechanisms in ALS , 2011, Current molecular medicine.

[22]  Caroline Prunier,et al.  Molecular Imaging of Microglial Activation in Amyotrophic Lateral Sclerosis , 2012, PloS one.

[23]  A. Kengne,et al.  Effects of diabetes mellitus on amyotrophic lateral sclerosis: a systematic review , 2014, BMC Research Notes.

[24]  W. Robberecht,et al.  Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease , 2011, The Lancet Neurology.

[25]  Y. Naparstek,et al.  Wegener granulomatosis with back pain, periaortitis, and dural inflammation developing while receiving monthly cyclophosphamide. , 2006, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[26]  C. Trampal,et al.  18F-FDG PET detection of spinal leptomeningeal metastases from cerebral glioblastoma multiforme , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  J. Trojanowski,et al.  Microglial Activation Correlates with Disease Progression and Upper Motor Neuron Clinical Symptoms in Amyotrophic Lateral Sclerosis , 2012, PloS one.

[28]  J. Cedarbaum,et al.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function , 1999, Journal of the Neurological Sciences.

[29]  C. Campi,et al.  Allogeneic cell transplant expands bone marrow distribution by colonizing previously abandoned areas: an FDG PET/CT analysis. , 2015, Blood.

[30]  C. Campi,et al.  Adult advanced chronic lymphocytic leukemia: computational analysis of whole-body CT documents a bone structure alteration. , 2014, Radiology.

[31]  Michele Piana,et al.  Hough Transform of Special Classes of Curves , 2013, SIAM J. Imaging Sci..

[32]  A. Ludolph,et al.  Amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.

[33]  C. Campi,et al.  Estimating the whole bone-marrow asset in humans by a computational approach to integrated PET/CT imaging , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[34]  M. Filippi,et al.  Neuroimaging in amyotrophic lateral sclerosis: insights into structural and functional changes , 2014, The Lancet Neurology.

[35]  M Ariet,et al.  Determination of ideal body weight for drug dosage calculations. , 1983, American journal of hospital pharmacy.